A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease

被引：18
|
作者：
Sood, S. L. [1 ]
James, A. H. [2 ]
Ragni, M. V. [3 ,4 ]
Shapiro, A. D. [5 ]
Witmer, C. [6 ,7 ]
Vega, R. [7 ]
Bolgiano, D. [8 ]
Konkle, B. A. [8 ,9 ]
机构：
[1] Univ Michigan, Hematol Oncol, Ann Arbor, MI 48109 USA
[2] Duke Univ, Med Ctr, Dept OB GYN, Durham, NC USA
[3] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA
[4] Hemophilia Ctr Western Penn, Pittsburgh, PA USA
[5] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
[6] Childrens Hosp Philadelphia, Hematol, Philadelphia, PA 19104 USA
[7] Univ Penn, Philadelphia, PA 19104 USA
[8] Bloodworks Northwest, Seattle, WA USA
[9] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA
来源：
HAEMOPHILIA | 2016年 / 22卷 / 06期
关键词：
FACTOR-VIII; MANAGEMENT; PUERPERIUM; DIAGNOSIS; MARKERS;
D O I：
10.1111/hae.13086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E562 / E564
页数：3
相关论文
共 50 条
  • [21] Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women
    Miller, CH
    Dilley, A
    Richardson, L
    Hooper, WC
    Evatt, BL
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 67 (02) : 125 - 129
  • [22] Von Willebrand disease
    Calmette, L.
    Clauser, S.
    REVUE DE MEDECINE INTERNE, 2018, 39 (12): : 918 - 924
  • [23] Interaction of factor VIII and von Willebrand factor and the identification of type 2 N von Willebrand disease
    Favaloro, Emmanuel J.
    THROMBOSIS RESEARCH, 2011, 127 (01) : 2 - 3
  • [24] Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study
    Eikenboom, J.
    Hilbert, L.
    Ribba, A. S.
    Hommais, A.
    Habart, D.
    Messenger, S.
    Al-Buhairan, A.
    Guilliatt, A.
    Lester, W.
    Mazurier, C.
    Meyer, D.
    Fressinaud, E.
    Budde, U.
    Will, K.
    Schneppenheim, R.
    Obser, T.
    Marggraf, O.
    Eckert, E.
    Castaman, G.
    Rodeghiero, F.
    Federici, A. B.
    Batlle, J.
    Goudemand, J.
    Ingerslev, J.
    Lethagen, S.
    Hill, F.
    Peake, I.
    Goodeve, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) : 1304 - 1312
  • [25] Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels
    Bucciarelli, P.
    Siboni, S. M.
    Stufano, F.
    Biguzzi, E.
    Canciani, M. T.
    Baronciani, L.
    Pagliari, M. T.
    La Marca, S.
    Mistretta, C.
    Rosendaal, F. R.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (02) : 228 - 236
  • [26] A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
    Lai, Shiue-Wei
    Chang, Chia-Yau
    Cheng, Shin-Nan
    Hu, Shu-Hsia
    Lai, Chung-Yu
    Chen, Yeu-Chin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 5167 - 5174
  • [27] Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD
    Roberts, Jonathan C.
    Christopherson, Pamela A.
    Tarantino, Michael D.
    Gonzales, Sarah E.
    Morateck, Patti A.
    Perry, Crystal L.
    Flood, Veronica H.
    Abshire, Thomas C.
    Montgomery, Robert R.
    HAEMOPHILIA, 2024, 30 (01) : 161 - 168
  • [28] Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study
    Krahforst, Alexander
    Yadegari, Hamideh
    Pavlova, Anna
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Poetzsch, Bernd
    Scholz, Ute
    Richter, Heinrich
    Trobisch, Heiner
    Liebscher, Karin
    Olivieri, Martin
    Trautmann-Grill, Karolin
    Knoefler, Ralf
    Halimeh, Susan
    Oldenburg, Johannes
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (11) : 3010 - 3034
  • [29] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [30] Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin®):: a prospective study of 50 patients
    Borel-Derlon, A.
    Federici, A. B.
    Roussel-Robert, V.
    Goudemand, J.
    Lee, C. A.
    Scharrer, I.
    Rothschild, C.
    Berntorp, E.
    Henriet, C.
    Tellier, Z.
    Bridey, F.
    Mannucci, P. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) : 1115 - 1124
12345